U.S.
Liquidia Up 26.6% as It Agrees to Pay $175 Million to End the Lawsuits
Liquidia rose 26.6% after an 8-K showed a settlement of patent and trade-secret litigation with United Therapeutics.
1 article(s) on Korean Pulmonary hypertension stocks, checked against filings and numbers.
Liquidia rose 26.6% after an 8-K showed a settlement of patent and trade-secret litigation with United Therapeutics.